228 related articles for article (PubMed ID: 30861137)
1. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties.
Luetzenberg FS; Jiang N
Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137
[TBL] [Abstract][Full Text] [Related]
2. Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study.
Abrahami D; McDonald EG; Schnitzer M; Azoulay L
BMJ Open; 2020 Dec; 10(12):e041529. PubMed ID: 33293322
[TBL] [Abstract][Full Text] [Related]
3. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
4. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
5. National Trends for Medicare Prescriptions of Antireflux Medications.
Fass OZ; Poels KE
Gastroenterology; 2020 Jul; 159(1):378-380.e3. PubMed ID: 32222398
[No Abstract] [Full Text] [Related]
6. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
Luo H; Fan Q; Xiao S; Chen K
BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
[TBL] [Abstract][Full Text] [Related]
7. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
[TBL] [Abstract][Full Text] [Related]
8. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a Guideline to Decrease Use of Acid-Suppressing Medications in the NICU.
Angelidou A; Bell K; Gupta M; Tropea Leeman K; Hansen A
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29162657
[TBL] [Abstract][Full Text] [Related]
10. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
11. Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment.
Masarwa R; Reynier P; Lefebvre C; Platt RW; Delaney JAC; Filion KB
Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5752. PubMed ID: 38362652
[TBL] [Abstract][Full Text] [Related]
12. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
13. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
15. Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior.
Lacy BE; Crowell MD; Riesett RP; Mitchell A
J Clin Gastroenterol; 2005 Jul; 39(6):489-94. PubMed ID: 15942434
[TBL] [Abstract][Full Text] [Related]
16. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
17. Changing impact of gastroesophageal reflux in medical and otolaryngology practice.
Altman KW; Stephens RM; Lyttle CS; Weiss KB
Laryngoscope; 2005 Jul; 115(7):1145-53. PubMed ID: 15995499
[TBL] [Abstract][Full Text] [Related]
18. Trends in Oral Antibiotic, Proton Pump Inhibitor, and Histamine 2 Receptor Blocker Prescription Patterns for Children Compared With Adults: Implications for Clostridium difficile Infection in the Community.
Faden HS; Ma CX
Clin Pediatr (Phila); 2016 Jul; 55(8):712-6. PubMed ID: 26350427
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
